Revolutionizing Genomic Surveillance with AI-Driven Intelligence
TranslateMyDNA is pioneering the next generation of genomic intelligence platforms, combining whole-genome sequencing with artificial intelligence to transform pathogen surveillance, antimicrobial resistance detection, and outbreak response.
Public health laboratories and clinical facilities face critical challenges in genomic analysis: traditional methods take days to weeks, require specialized expertise, and often miss critical resistance patterns. Meanwhile, antimicrobial-resistant infections cause 1.27 million deaths annually and cost healthcare systems billions.
The market needs faster, smarter, and more accessible genomic intelligence.
TranslateMyDNA delivers a comprehensive AI-powered genomic analysis platform that reduces analysis time from days to hours while improving accuracy and clinical actionability. Our technology enables:
Automated Nextflow pipelines process whole-genome sequencing data 120x faster than traditional methods, delivering results in hours instead of days.
Machine learning algorithms predict antimicrobial resistance patterns, detect emerging threats, and identify outbreak clusters with unprecedented accuracy.
Automated interpretation translates complex genomic data into clear clinical recommendations, enabling rapid treatment decisions.
Cloud-based platform enables public health networks to track pathogen evolution and coordinate outbreak responses in real-time.
The global genomics market is experiencing explosive growth:
Our addressable market includes public health laboratories, clinical microbiology facilities, academic research institutions, and pharmaceutical companies developing antimicrobial therapeutics.
Three years of experience at the CDC with national surveillance programs (eGISP, SURRG), data processing thousands of isolates.
Custom machine learning models trained on NCBI data provide superior resistance prediction and outbreak detection.
Platform improves with each sample processed, creating a data moat and continuous accuracy improvements.
✓ Technology Development: Production-ready platform processing bacterial pathogen genomes with comprehensive AMR profiling
✓ Clinical Validation: Three years of Bioinformatics validating accuracy and clinical utility
✓ Scientific Recognition: Peer-reviewed publications and conference presentations
✓ Strategic Partnerships: Established relationships with public health laboratory networks
✓ Expanding Platform: Roadmap includes human genomics, animal health, and plant pathogen applications
TranslateMyDNA operates a SaaS-based platform with multiple revenue streams:
Transaction-based pricing for individual genomic analyses, scalable across laboratory networks.
Enterprise licensing for integrated laboratory information systems and surveillance networks.
Aggregated epidemiological intelligence and trend analysis for pharmaceutical and biotech companies.
We're seeking strategic partners to accelerate platform development and market expansion.
Contact us to receive our complete pitch deck and financial projections.
For confidential inquiries, reach out directly to: investors@translatemydna.com